iiinova — where your digital self keeps evolving

Replies

iiinova is part of the Atmosphere — an open, public network where you own your identity.

Replies

ME/CFS Science @mecfsscience.org · 05/07/2026

3) The WE&ME Foundation launched an ambitious grant program that was co-developed by members of the Science for ME forum. It aims to fund 7 projects with a budget of €120,000-180,000 per project. bsky.app/profile/mecf...

ME/CFS Science@mecfsscience.org

1) The WE&ME Foundation has launched a major international call for ME/CFS research in collaboration with the Science for ME forum. It aims to fund 7 projects with a budget of €120,000-180,000 per project. The stage 1, short proposal, deadline is 25 August 2026.

1132 13

ME/CFS Science @mecfsscience.org · 05/07/2026

4) In Norway, the research team of Fluge & Mella is proceeding with ResetME-study: a randomized trial of the cancer drug daratumumab with funding for the Norwegian ME Association. A pilot trial already showed positive results bsky.app/profile/mecf...

ME/CFS Science@mecfsscience.org

1) The pilot results (n = 10) for the Daratumumab trial on ME/CFS have been published and they look quite encouraging. Tolerability and feasibility were good and some patients had substantial improvements.

2131 13

Evelyn! @umbellule.bsky.social · 09/07/2026

I think trials like this need to start coordinating w genome-mapping studies. if all the participants are mapped, maybe we can find genetic patterns in those that respond to a treatment; the goal being able to tell if a patient will respond based on a simple test for a specific genetic marker

010 1

ME/CFS Science @mecfsscience.org · 05/07/2026

5) The German government has launched the ‘Decade against post-infectious diseases’. They plan to spend € 500 million in research on ME/CFS and Long Covid. bsky.app/profile/mecf...

ME/CFS Science@mecfsscience.org

1) 🇩🇪 Some really good news! Germany plans to invest half a billion euros in research on diseases such as ME/CFS and Long Covid. They are calling it "The National Decade Against Post-Infectious Diseases"

1121 12